AKT1 and breast cancer: Therefore, EHop-016 and MBQ-167 inhibit Rac and Cdc42 activation in macrophage cell lines at concentrations ~5X higher than the effective concentrations for Rac and Cdc42 inhibition in breast cancer cell lines (See full length westerns in Supplementary Figure S1).